Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers.
about
Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice.Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure.Key Pharmacokinetic Essentials of Fixed-Dosed Combination Products: Case Studies and Perspectives.
P2860
Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative steady-state pharm ...... ulation in healthy volunteers.
@en
Comparative steady-state pharm ...... ulation in healthy volunteers.
@nl
type
label
Comparative steady-state pharm ...... ulation in healthy volunteers.
@en
Comparative steady-state pharm ...... ulation in healthy volunteers.
@nl
prefLabel
Comparative steady-state pharm ...... ulation in healthy volunteers.
@en
Comparative steady-state pharm ...... ulation in healthy volunteers.
@nl
P2093
P2860
P356
P1476
Comparative steady-state pharm ...... ulation in healthy volunteers.
@en
P2093
Dong-Hyun Chee
Howard Lee
In-Jin Jang
Kyung-Sang Yu
Seonghae Yoon
SeungHwan Lee
Tae-Eun Kim
P2860
P304
P356
10.2147/DDDT.S53027
P407
P50
P577
2014-01-15T00:00:00Z